Travere Therapeutics Inc (TVTX)
5.80
-0.20
(-3.25%)
USD |
NASDAQ |
Apr 18, 16:00
5.80
0.00 (0.00%)
After-Hours: 19:08
Travere Therapeutics Free Cash Flow: -322.28M for Dec. 31, 2023
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| December 31, 2023 | -322.28M |
| September 30, 2023 | -305.11M |
| June 30, 2023 | -287.73M |
| March 31, 2023 | -263.34M |
| December 31, 2022 | -214.85M |
| September 30, 2022 | -188.09M |
| June 30, 2022 | -114.09M |
| March 31, 2022 | -63.79M |
| December 31, 2021 | -38.94M |
| September 30, 2021 | -124.62M |
| June 30, 2021 | -151.48M |
| March 31, 2021 | -164.56M |
| December 31, 2020 | -162.59M |
| September 30, 2020 | -53.31M |
| June 30, 2020 | -71.47M |
| March 31, 2020 | -83.08M |
| December 31, 2019 | -73.78M |
| September 30, 2019 | -72.74M |
| June 30, 2019 | -62.14M |
| March 31, 2019 | -46.14M |
| December 31, 2018 | -44.66M |
| September 30, 2018 | -41.02M |
| June 30, 2018 | -30.82M |
| March 31, 2018 | -21.87M |
| December 31, 2017 | -6.606M |
| Date | Value |
|---|---|
| September 30, 2017 | -15.54M |
| June 30, 2017 | -16.16M |
| March 31, 2017 | -16.92M |
| December 31, 2016 | -15.36M |
| September 30, 2016 | -7.917M |
| June 30, 2016 | -11.80M |
| March 31, 2016 | -7.018M |
| December 31, 2015 | -8.419M |
| September 30, 2015 | -12.32M |
| June 30, 2015 | -25.94M |
| March 31, 2015 | -47.35M |
| December 31, 2014 | -49.81M |
| September 30, 2014 | -54.31M |
| June 30, 2014 | -41.32M |
| March 31, 2014 | -28.59M |
| December 31, 2013 | -23.14M |
| September 30, 2013 | -9.442M |
| June 30, 2013 | -6.787M |
| March 31, 2013 | -4.579M |
| November 30, 2012 | 0.00 |
| August 31, 2012 | 0.00 |
| May 31, 2012 | 0.00 |
| February 29, 2012 | 0.00 |
| November 30, 2011 | -0.0006M |
| August 31, 2011 | -0.0007M |
Free Cash Flow Range, Past 5 Years
-322.28M
Minimum
Dec 2023
-38.94M
Maximum
Dec 2021
-148.32M
Average
-124.62M
Median
Sep 2021
Free Cash Flow Benchmarks
| AtriCure Inc | -37.51M |
| Bio-Rad Laboratories Inc | 218.26M |
| Artivion Inc | 11.40M |
| Shockwave Medical Inc | 165.46M |
| Perspective Therapeutics Inc | -37.98M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -70.47M |
| Cash from Investing (Quarterly) | -16.95M |
| Cash from Financing (Quarterly) | 0.124M |
| Free Cash Flow Per Share (Quarterly) | -0.9935 |
| Free Cash Flow to Equity (Quarterly) | -76.43M |
| Free Cash Flow to Firm (Quarterly) | -76.00M |
| Free Cash Flow Yield | -74.84% |